Captopril versus atenolol to prevent expansion rate of thoracic aortic aneurysms: rationale and design
M Spartalis, E Tzatzaki, DC Iliopoulos… - Future …, 2020 - Future Medicine
Thoracic aortic aneurysms are correlated with significant mortality and morbidity. No therapy,
however, is effective at limiting aneurysm expansion and preventing rupture. Angiotensin …
however, is effective at limiting aneurysm expansion and preventing rupture. Angiotensin …
Captopril versus atenolol to prevent expansion rate of thoracic aortic aneurysms: rationale and design
M Spartalis, E Tzatzaki, DC Iliopoulos… - Future …, 2021 - pubmed.ncbi.nlm.nih.gov
Thoracic aortic aneurysms are correlated with significant mortality and morbidity. No therapy,
however, is effective at limiting aneurysm expansion and preventing rupture. Angiotensin …
however, is effective at limiting aneurysm expansion and preventing rupture. Angiotensin …
Captopril versus atenolol to prevent expansion rate of thoracic aortic aneurysms: rationale and design.
M Spartalis, E Tzatzaki, DC Iliopoulos, E Spartalis… - Future …, 2020 - europepmc.org
Thoracic aortic aneurysms are correlated with significant mortality and morbidity. No therapy,
however, is effective at limiting aneurysm expansion and preventing rupture. Angiotensin …
however, is effective at limiting aneurysm expansion and preventing rupture. Angiotensin …